Bufotalin Suppresses Proliferation and Metastasis of Triple-Negative Breast Cancer Cells by Promoting Apoptosis and Inhibiting the STAT3/EMT Axis
Molecules · 2023
DOI: 10.3390/molecules28196783 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von So Jin Park und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science and Biochemical Engineering, Graduate School, Sun Moon University, Asan 31460, Republic of Korea. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Bufanolides. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Basic Science Research Program through the National Research Foundation of Korea, Brain Korea 21 Project.
Abstract (Originalsprache)
Triple-negative breast cancer (TNBC) is a highly aggressive type of breast cancer and has a poor prognosis. As standardized TNBC treatment regimens cause drug resistance and tumor recurrence, the development of new TNBC treatment strategies is urgently required. Bufotalin is a bufadienolide isolated from the skin and parotid venom glands of the toad Bufo gargarizan, and has several pharmacological properties, including antiviral, anti-inflammatory, and anticancer activities. However, the anticancer effect and underlying molecular mechanisms of action of bufotalin in TNBC have not been fully studied. In the current study, we investigated the effects of bufotalin on the growth and metastasis of MDA-MB-231 and HCC1937 TNBC cells. Bufotalin potently inhibited the proliferation of both TNBC cell lines by promoting cell cycle arrest and caspase-mediated apoptosis. Furthermore, bufotalin effectively suppressed the migration and invasion of both TNBC cell lines by regulating the expression of key epithelial-mesenchymal transition (EMT) biomarkers, matrix metalloproteinases (MMPs), and integrin α6. Notably, the anticancer effect of bufotalin in TNBC cells was associated with the downregulation of the signal transducer and activator of the transcription 3 (STAT3) signaling pathway. Collectively, our results suggest that the natural compound bufotalin may exert antiproliferative and antimetastatic activities in TNBC cells by modulating the apoptotic pathway and the STAT3/EMT axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Science and Biochemical Engineering, Graduate School, Sun Moon University, Asan 31460, Republic of Korea.
- Department of Pharmaceutical Engineering and Biotechnology, Sun Moon University, Asan 31460, Republic of Korea.
- Genome-Based BioIT Convergence Institute, Sun Moon University, Asan 31460, Republic of Korea.
ORCID-Profile: So Jin Park, Hye Jin Jung
Förderung
- Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education
- Basic Science Research Program through the National Research Foundation of Korea
- Brain Korea 21 Project
Zitieren
APA
Park, S. J., & Jung, H. J. (2023). Bufotalin Suppresses Proliferation and Metastasis of Triple-Negative Breast Cancer Cells by Promoting Apoptosis and Inhibiting the STAT3/EMT Axis. Molecules. https://doi.org/10.3390/molecules28196783
Vancouver
Park SJ, Jung HJ. Bufotalin Suppresses Proliferation and Metastasis of Triple-Negative Breast Cancer Cells by Promoting Apoptosis and Inhibiting the STAT3/EMT Axis. Molecules. 2023. doi:10.3390/molecules28196783
BibTeX
@article{Park2023,
author = {Park, So Jin and Jung, Hye Jin},
title = {Bufotalin Suppresses Proliferation and Metastasis of Triple-Negative Breast Cancer Cells by Promoting Apoptosis and Inhibiting the STAT3/EMT Axis},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28196783}
}
EUVIMED